SEC

Aduro stung as Novartis drops work on STING drug
Aduro stung as Novartis drops work on STING drug
Fierce Biotech
Aduro BioTech
Novartis
SEC
ADU-S100
Flag link:
Bankrupt Insys offers to turn out its almost empty pockets for plaintiffs
Bankrupt Insys offers to turn out its almost empty pockets for plaintiffs
Fierce Pharma
Insys
bankruptcy
SEC
DOJ
Flag link:
As Osiris moves on from fraudulent past, one exec settles up with SEC
As Osiris moves on from fraudulent past, one exec settles up with SEC
Endpoints
Osiris Therapeutics
SEC
Flag link:
Mylan Stock Dives On $30 Million Settlement In EpiPen Scandal
Mylan Stock Dives On $30 Million Settlement In EpiPen Scandal
Investors Business Daily
Mylan
SEC
EpiPen
Flag link:
SEC Charges TherapeuticsMD for Selectively Disclosing Info From FDA Meeting
SEC Charges TherapeuticsMD for Selectively Disclosing Info From FDA Meeting
RAPS.org
TherapeuticsMD
SEC
FDA
Flag link:
BIO tells SEC: do away with quarterly reports for small biotechs
BIO tells SEC: do away with quarterly reports for small biotechs
Endpoints
BIO
SEC
biotechs
quarterly reports
Flag link:
BioSig raises $9m
BioSig raises $9m
Mass Device
SEC
BioSig Technologies
Pure EP System
electrocardiography
Flag link:
Bristol-Myers Gets FTC Request for More Information on $74 Billion Celgene Deal
Bristol-Myers Gets FTC Request for More Information on $74 Billion Celgene Deal
TheStreet.com
SEC
FTC
M&A
Bristol-Myers Squibb
Celgene
Flag link:
Biotechs Scramble to Get IPOs Moving Now That Government Is Open
Biotechs Scramble to Get IPOs Moving Now That Government Is Open
BioSpace
IPOs
SEC
Flag link:
As shutdown stalls IPOs, companies mull creative paths to market
As shutdown stalls IPOs, companies mull creative paths to market
Biopharma Dive
SEC
NASDAQ
IPOs
Flag link:
Uncertainty Grows for Biotech as Government, FDA Shutdown Drags On
Uncertainty Grows for Biotech as Government, FDA Shutdown Drags On
Xconomy
government shutdown
FDA
SEC
Flag link:
Novartis files for Alcon spinoff, citing aging population and developing countries as top growth prospects
Novartis files for Alcon spinoff, citing aging population and developing countries as top growth prospects
Fierce Pharma
Novartis
Alcon
spinoffs
SEC
eye health
Flag link:
Stryker pays $8m to settle second SEC beef
Stryker pays $8m to settle second SEC beef
Mass Device
devices
Stryker
SEC
Flag link:
Clovis Oncology to Pay the SEC $20 Million for Misleading Investors
Clovis Oncology to Pay the SEC $20 Million for Misleading Investors
BioSpace
Clovis Oncology
SEC
investors
lung cancer
rociletinib
Flag link:
Pharma Billionaire Frost 'Stunned' By SEC Charges, Swears He Will Clear His Name
Pharma Billionaire Frost 'Stunned' By SEC Charges, Swears He Will Clear His Name
Forbes
OPKO Health
SEC
Phillip Frost
Flag link:
OPKO Responds to Nasdaq Halt of Trading of Common Shares
OPKO Responds to Nasdaq Halt of Trading of Common Shares
CP Wire
OPKO Health
SEC
Phillip Frost
Flag link:
OPKO Responds to Nasdaq Halt of Trading of Common Shares
OPKO Health
SEC
Flag link:
Biotech billionaire Phillip Frost charged by SEC, sending Opko shares sliding
Biotech billionaire Phillip Frost charged by SEC, sending Opko shares sliding
Biopharma Dive
OPKO Health
Phillip Frost
SEC
Flag link:
SEC charges former Sangamo exec, others with insider trading
SEC charges former Sangamo exec, others with insider trading
Biopharma Dive
SEC
Sangamo
insider trading
Flag link:
Clovis writes a $20 million check payable to the SEC, hoping to rid itself of the lingering roci probe
Clovis writes a $20 million check payable to the SEC, hoping to rid itself of the lingering roci probe
Endpoints
Clovis Oncology
SEC
rociletinib
Flag link:

Pages